A new anticancer drug for Leukemia has been approved by FDA. The drug treats chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects seniors.
It works by inhibiting the enzyme Tyrosine Kinase.
Bosutinib – Bosulif approved for Leukemia by Pfizer
·
Leave a Reply